0882 The Association Between Objective Daytime Sleepiness and Glucose Metabolism in OSA Patients: A Metabolomics Study

Yun Li,Le Chen,Baixin Chen,Yanyuan Dai,Alexandros Vgontzas
DOI: https://doi.org/10.1093/sleep/zsae067.0882
IF: 6.313
2024-04-20
SLEEP
Abstract:Abstract Introduction Objective, but not subjective excessive daytime sleepiness (EDS) has been proposed to link to cardiometabolic comorbidity in obstructive sleep apnea (OSA). We aimed to examine the joint effect of OSA and objective EDS on glucose metabolism and the underlying mechanisms. Methods The multiple sleep latency test (MSLT) and Epworth sleepiness scale (ESS) were used to assess objective and subjective EDS, respectively. Disordered glucose metabolism was defined as either a physician-diagnosis or having fasting blood glucose levels ≥ 5.6 mmol/L. Values of fasting insulin and homeostasis model assessment of insulin resistance (HOMA-IR) higher or equal to the median values of our sample were defined as high fasting insulin and insulin resistance. Serum metabolomics was used to explore the underlying pathways. Results Among 114 consecutive OSA patients, lower MSLT values was marginally significantly associated with higher levels of fasting blood glucose (β = −0.181, p = 0.052, poor strength), and significantly associated with insulin (β = −0.308, p = 0.002, fair strength) and HOMA-IR (β = −0.321, p = 0.001, fair strength). Furthermore, objective EDS was significantly associated with increased odds of disordered glucose metabolism (OR = 5.781, 95%CI 1.232 - 27.135), elevated fasting insulin (OR = 4.317, 95%CI 1.357 - 13.731) and insulin resistance (OR = 5.621, 95%CI 1.581 - 19.984). Metabolomics analyses showed that dysregulation of valine-related metabolism linked the association between objective EDS and impaired glucose metabolism in patients with OSA. No association between subjective EDS and impaired glucose metabolism was observed. Conclusion OSA with objective, but not subjective EDS is associated with impaired glucose metabolism. Dysregulation of valine-related metabolism may contribute to the association between objective EDS and impaired glucose metabolism in OSA. Support (if any) This study was supported by the National Natural Science Foundation of China [No.81970087; No.82270105; No.82300117] and 2020 Li Ka Shing Foundation Cross-Disciplinary Research Grant [2020LKSFG05B].
neurosciences,clinical neurology
What problem does this paper attempt to address?